0001691479-18-000001.txt : 20180824 0001691479-18-000001.hdr.sgml : 20180824 20180824130821 ACCESSION NUMBER: 0001691479-18-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180824 DATE AS OF CHANGE: 20180824 EFFECTIVENESS DATE: 20180824 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ApoGen Biotechnologies, Inc. CENTRAL INDEX KEY: 0001691479 IRS NUMBER: 471760599 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-275911 FILM NUMBER: 181036484 BUSINESS ADDRESS: STREET 1: 1616 EASTLAKE AVE E. STREET 2: SUITE 200 CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: 206-957-7300 MAIL ADDRESS: STREET 1: 1616 EASTLAKE AVE E. STREET 2: SUITE 200 CITY: SEATTLE STATE: WA ZIP: 98102 D/A 1 primary_doc.xml X0708 D/A LIVE 0001691479 ApoGen Biotechnologies, Inc. 1616 EASTLAKE AVE E. SUITE 200 SEATTLE WA WASHINGTON 98102 206-957-7300 DELAWARE None None Corporation true 2014 Thong Le c/o ApoGen Biotechnologies, Inc. 1616 Eastlake Ave E., Suite 200 Seattle WA WASHINGTON 98102 Executive Officer Director Keno Gutierrez c/o ApoGen Biotechnologies, Inc. 1616 Eastlake Ave E., Suite 200 Seattle WA WASHINGTON 98102 Director Steve Gillis c/o ApoGen Biotechnologies, Inc. 1616 Eastlake Ave E., Suite 200 Seattle WA WASHINGTON 98102 Director Asish Xavier c/o ApoGen Biotechnologies, Inc. 1616 Eastlake Ave E., Suite 200 Seattle WA WASHINGTON 98102 Director M. Johnston Erwin c/o ApoGen Biotechnologies, Inc. 1616 Eastlake Ave E., Suite 200 Seattle WA WASHINGTON 98102 Director Joel Marcus c/o ApoGen Biotechnologies, Inc. 1616 Eastlake Ave E., Suite 200 Seattle WA WASHINGTON 98102 Director James Sullivan AbbVie House, Vanwall Business Park 1616 Eastlake Ave E., Suite 200 Seattle WA WASHINGTON 98102 Director John Santini c/o ApoGen Biotechnologies, Inc. 1616 Eastlake Ave E., Suite 200 Seattle WA WASHINGTON 98102 Director Ian A.W. Howes c/o ApoGen Biotechnologies, Inc. 1616 Eastlake Ave E., Suite 200 Seattle WA WASHINGTON 98102 Executive Officer Biotechnology Decline to Disclose 06b true 0001691479-16-000001 2016-11-23 true true false 0 7565892 7565892 0 false 24 0 0 0 false ApoGen Biotechnologies, Inc. /s/ Thong Q. Le Thong Q. Le CEO 2018-08-24